Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Staels

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Liver|September 11, 2002
Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC)E Sturm, C F M Franssen, A Gouw, et al.
Diabetes|November 28, 2001
PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistanceM Guerre-Millo, C Rouault, P Poulain, et al.
The Journal of Biological Chemistry|August 10, 2001
Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse linesT E Akiyama, C J Nicol, C Fievet, et al.
FEBS Letters|December 20, 2000
Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cellsC Faveeuw, S Fougeray, V Angeli, et al.
Diabetologia|October 5, 2011
Downregulation of the tumour suppressor p16INK4A contributes to the polarisation of human macrophages toward an adipose tissue macrophage (ATM)-like phenotypeL Fuentes, K Wouters, S A Hannou, et al.
The Journal of Biological Chemistry|November 5, 1999
Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1P Delerive, K De Bosscher, S Besnard, et al.
Clinical Pharmacology and Therapeutics|June 13, 2013
Profiling serum bile acid glucuronides in humans: gender divergences, genetic determinants, and response to fenofibrateJ Trottier, M Perreault, I Rudkowska, et al.
Circulation|May 24, 2000
CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptorsG Chinetti, F G Gbaguidi, S Griglio, et al.
The Journal of Biological Chemistry|May 9, 2001
Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrateM Bouly, D Masson, B Gross, et al.
Atherosclerosis|June 16, 2004
European Lipoprotein Club: report of the 26th ELC Annual Conference, Tutzing, 8-11 September 2003M Hofker, L Calabresi, M Jauhiainen, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Liver|September 11, 2002
Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC)E Sturm, C F M Franssen, A Gouw, et al.
Diabetes|November 28, 2001
PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistanceM Guerre-Millo, C Rouault, P Poulain, et al.
The Journal of Biological Chemistry|August 10, 2001
Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse linesT E Akiyama, C J Nicol, C Fievet, et al.
FEBS Letters|December 20, 2000
Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cellsC Faveeuw, S Fougeray, V Angeli, et al.
Diabetologia|October 5, 2011
Downregulation of the tumour suppressor p16INK4A contributes to the polarisation of human macrophages toward an adipose tissue macrophage (ATM)-like phenotypeL Fuentes, K Wouters, S A Hannou, et al.
The Journal of Biological Chemistry|November 5, 1999
Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1P Delerive, K De Bosscher, S Besnard, et al.
Clinical Pharmacology and Therapeutics|June 13, 2013
Profiling serum bile acid glucuronides in humans: gender divergences, genetic determinants, and response to fenofibrateJ Trottier, M Perreault, I Rudkowska, et al.
Circulation|May 24, 2000
CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptorsG Chinetti, F G Gbaguidi, S Griglio, et al.
The Journal of Biological Chemistry|May 9, 2001
Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrateM Bouly, D Masson, B Gross, et al.
Atherosclerosis|June 16, 2004
European Lipoprotein Club: report of the 26th ELC Annual Conference, Tutzing, 8-11 September 2003M Hofker, L Calabresi, M Jauhiainen, et al.
Pageof 20